Literature DB >> 30991429

Clinical Ultrasound in Inflammatory Bowel Disease.

Georg Kunze1, Karlheinz Seitz2, Martin Mauch3, Frauke Petersen4.   

Abstract

Ultrasound should be the first-line imaging method in the medical care of patients with inflammatory bowel disease. It can be used to differentiate between Crohn's disease and ulcerative colitis and to detect numerous complications like stenoses, fistulas, and abscesses. As the method is also highly suitable for follow-up, stressful endoscopic procedures and examinations involving radiation are less necessary. Comparison studies with MRI and CT show that ultrasound is not an inferior method and it is therefore included in all guidelines. Intensifying physician training in this method will help to ensure its comprehensive use. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 30991429     DOI: 10.1055/a-0869-8799

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  4 in total

Review 1.  Update in Contrast-Enhanced Ultrasound.

Authors:  Steffen Beckmann; Jörg H Simanowski
Journal:  Visc Med       Date:  2020-11-26

2.  Bowel wall thickening and hyperemia assessed by high-frequency ultrasound indicate histological inflammation in Crohn's ileitis.

Authors:  Ruediger S Goertz; Stefanie Hensel; Dane Wildner; Markus F Neurath; Deike Strobel
Journal:  Abdom Radiol (NY)       Date:  2020-12-24

3.  In vivo visualization and characterization of inflamed intestinal wall: the exploration of targeted microbubbles in assessing NF-κB expression.

Authors:  Chenyang Zhao; Li Ma; Yanwen Luo; Wenbo Li; Mengsu Xiao; Qingli Zhu; Yuxin Jiang
Journal:  J Cell Mol Med       Date:  2021-08-19       Impact factor: 5.310

4.  Cumulative Effective Dose from Medical Imaging in Inflammatory Bowel Disease.

Authors:  Agata Łukawska; Dominika Ślósarz; Aneta Zimoch; Karol Serafin; Elżbieta Poniewierka; Radosław Kempiński
Journal:  Diagnostics (Basel)       Date:  2021-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.